Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fatemeh Sharifi is active.

Publication


Featured researches published by Fatemeh Sharifi.


Scientia Pharmaceutica | 2017

Leishmanicidal Activity of Biogenic Fe3O4 Nanoparticles

Mehrdad Khatami; Hajar Q. Alijani; Iraj Sharifi; Fatemeh Sharifi; Shahram Pourseyedi; Sam Kharazi; Marcos Augusto Lima Nobre; Manouchehr Khatami

Due to the multiplicity of useful applications of metal oxide nanoparticles (ONPs) in medicine are growing exponentially, in this study, Fe3O4 (iron oxide) nanoparticles (IONPs) were biosynthesized using Rosemary to evaluate the leishmanicidal efficiency of green synthesized IONPs. This is the first report of the leishmanicidal efficiency of green synthesized IONPs against Leishmania major. The resulting biosynthesized IONPs were characterized by ultraviolet-visible spectroscopy (UV-Vis), X-ray diffraction (XRD), transmission electron microscopy (TEM), and Fourier transform infrared spectroscopy (FTIR). The leishmanicidal activity of IONPS was studied via 3-4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The results showed the fabrication of the spherical shape of monodisperse IONPs with a size 4 ± 2 nm. The UV-visible spectrophotometer absorption peak was at 334 nm. The leishmanicidal activity of biogenic iron oxide nanoparticles against Leishmania major (promastigote) was also studied. The IC50 of IONPs was 350 µg/mL. In this report, IONPs were synthesized via a green method. IONPs are mainly spherical and homogeneous, with an average size of about 4 nm, and were synthesized here using an eco-friendly, simple, and inexpensive method.


PLOS ONE | 2018

Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran

Mehdi Bamorovat; Iraj Sharifi; Mohammad Reza Aflatoonian; Ali Karamoozian; Fatemeh Sharifi; Ahmad Khosravi; Saeid Hassanzadeh

Cutaneous leishmaniasis (CL) is a serious health challenge at the global level due to Leishmania tropica. This study was conducted to evaluate the risk factors associated with anthroponotic CL (ACL) in unresponsive (patient who does not heal and remains with an active lesion, despite receiving two courses of intra-lesional Glucantime along with cryotherapy and one cycle of systemic Glucantime) and responsive patients in a major focus in southeastern Iran. A case-control study was conducted from April 2015 to October 2016 in the southeast of Iran. Patients were recruited in a major ACL focus from unresponsive and responsive cases. These patients were compared for environmental, clinical, and demographic characteristic factors. Twenty-five risk related factors were analyzed using multivariate logistic regression and backward elimination stepwise models. P<0.05 was defined to be statistically significant. In general, 340 patients with ACL comprising 72 (21.2%) unresponsive cases and 268 (78.8%) responsive cases with active lesions or scars were analyzed by estimating odds ratio (OR). All isolates from 15 responsive and 15 unresponsive patients were characterized as Leishmania tropica based on the BLAST and phylogenic analyses by PCR sequences of the Hsp70 and ITS1 loci. Among the 25 variables, 4 major risk factors including poor interior housing conditions (OR = 1.99, confidence interval (CI) = 1–3.93, P<0.04), history of chronic diseases (OR = 6.22, CI = 2.51–15.44, P≤0.001), duration of lesion in the patients referred ≥13 months (OR = 74.99, CI = 17.24–326.17, P≤0.001), and 5–12 months (OR = 7.42, CI = 3.07–17.92, P≤0.001) than lesions with ≤4 months of age and age groups ≥51 years (OR = 3.85, CI = 1.04–14.22, P<0.04) than those ≤7 years, were significantly associated with unresponsive forms. Improving interior house construction protecting high risk individuals and those with debilitating diseases from being bitten by sand flies, together with the early detection and effective treatment of older age groups with history of chronic diseases are highly important measures for preventing unresponsive forms in patients with ACL in southeastern Iran.


Pathogens and Global Health | 2018

Geographical distribution and molecular characterization for cutaneous leishmaniasis species by sequencing and phylogenetic analyses of kDNA and ITS1 loci markers in south-eastern Iran

Maryam Ramezany; Iraj Sharifi; Zahra Babaei; Pooya Ghasemi Nejad Almani; Amireh Heshmatkhah; Alireza Keyhani; Mohammad Reza Aflatoonian; Mohammad Ali Mohammadi; Fatemeh Sharifi; Mehdi Bamorovat

Abstract This study aimed to explore geographic distribution and molecular characterization of cutaneous leishmaniasis (CL) species by amplifying two popular markers in kinetoplast DNA and internal transcribed spacer 1 loci by nested-PCR, and characterized by sequencing and phylogenetic analyses. Findings demonstrated that two species co-existed in the province: L. tropica (88.5%) and L. major (11.5%). All gender and age groups were equally infected, although males, 21–30 years old, exhibited a significantly higher infection. Sequencing and phylogenetic analyses of 34 randomly selected samples showed that L. tropica isolates exhibited some degree of heterogeneity. Both anthroponotic CL and zoonotic CL are present in south-eastern Iran with predominance of L. tropica species. Some level of heterogeneity was observed in L. tropica isolates which possibly reflects different colonies in the area. Implementation of diagnostic tools directly from clinical samples could be an important strategic approach for exploration of spatial distribution, molecular characterization and phylogenetic analyses.


Biochemical and Biophysical Research Communications | 2018

Vascular apoptosis associated with meglumine antimoniate: In vivo investigation of a chick embryo model

Ahmad Khosravi; Iraj Sharifi; Hadi Tavakkoli; Ali Reza Keyhani; Ali Afgar; Zohreh Salari; Seyedeh Saedeh Mosallanejad; Mehdi Bamorovat; Fatemeh Sharifi; Saeid Hassanzadeh; Balal Sadeghi; Shahriar Dabiri; Abbas Mortazaeizdeh; Zahra Sheikhshoaie; Ehsan Salarkia

The vasculo-toxic effect of meglumine antimoniate (MA) was confirmed in our previous investigation. The current study investigates the association of this effect with altered VEGF-A and VEGF-R2 expression. Additional mechanisms by which MA causes vascular toxicity are not clearly understood. We hypothesized that MA may alter normal expression of apoptotic genes and cause vascular toxicity. The current investigation was designed to address this issue using a chick embryo model. Fertile chicken eggs were treated with MA and the extra-embryonic membrane (EEM) vasculature was evaluated by morphometric, molecular and immunohistochemistry assays. The results showed that MA not only altered apoptotic gene expression, but that this alteration may disturb the normal development of the vascular network and cause embryo malformation. The relative expression level of the CASP3, CASP7, CASP9, APAF1, AIF1 and TP53 genes increased in drug-exposed EEMs. In addition, IHC assay confirmed the low expression BCL2 and increased expression of Bax, which are associated with a high rate of apoptosis. We suggest that induction of an apoptotic signaling pathway can lead to vascular defects during embryo development and the consecutive cascade of events can lead to the embryo malformation.


European journal of medicinal plants | 2017

Antioxidant, Anti-proliferation and Cytotoxicity Activities of Gossypium hirsutum toward Standard HepG2, A549, MCF-7 and U87 Cancer Cell Lines Compared to Huvec, 3T3 Normal Cells

Fatemeh Sharifi; Fariba Sharififar; Iraj Sharifi; Mostafa Pournamdari; Touba Eslaminejad; Mehrdad Khatami

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. Herbal and Traditional Medicines Research Center, Department of Pharmacognosy, Kerman University of Medical Sciences, Kerman, Iran. Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran. Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran. School of Medicine, Bam University of Medical Sciences, Bam, Iran. Nanomedicine and Nanobiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.


Iranian Journal of Parasitology | 2012

Spatial Distribution and Molecular Identification of Leishmania Species from Endemic Foci of South-Eastern Iran

Fatemeh Sharifi; Iraj Sharifi; Mehdi Zarean; M Hakimi Parizi; Aflatoonian; M Fasihi Harandi; R Zahmatkesh; M Mashayekhi; Alireza Kermanizadeh


Iranian Journal of Public Health | 2015

A Comprehensive Review of Cutaneous Leishmaniasis in Kerman Province, Southeastern Iran-Narrative Review Article

Iraj Sharifi; Mohammad Reza Aflatoonian; Ali Reza Fekri; Maryam Hakimi Parizi; Abbas Aghaei Afshar; Ahmad Khosravi; Fatemeh Sharifi; Behnaz Aflatoonian; Ali Khamesipour; Yahya Dowlati; Farrokh Modabber; Abolhasan Nadim


Iet Nanobiotechnology | 2017

Cytotoxicity, leishmanicidal, and antioxidant activity of biosynthesised zinc sulphide nanoparticles using Phoenix dactylifera

Fatemeh Sharifi; Fariba Sharififar; Iraj Sharifi; Hajar Q. Alijani; Mehrdad Khatami


Iranian Journal of Parasitology | 2017

PARACON 2017 International Parasitology Conference 25-26 Oct, 2017 Recent Advances and Emerging Issues in Parasitology

Iraj Sharifi; Mohammad Reza Aflatoonian; Mohammad Hossein Daei Parizi; Ali Hosseininasab; Mahshid Mostafavi; Mehdi Bamorovat; Abass Aghaei Afshar; Mehdi Mohebali; Hossein Keshavarz; Hamid Daneshvar; Zahra Babaei; Hossein Mahmoudvand; Mohammad Ali Mohammadi; Fatemeh Sharifi; Mohammad Barati; Hossein Kamiabi; Tabandeh Khaleghi


European journal of medicinal plants | 2018

Antileishmanial Effect of Coffea arabica, Salvia rhytidea and Bunium persicum against Leishmania major and Leishmania tropica Promastigotes and Their Cytotoxicity and Antioxidant Activities

Fatemeh Sharifi; Iraj Sharifi; Mostafa Pournamdari; Fariba Sharififar

Collaboration


Dive into the Fatemeh Sharifi's collaboration.

Researchain Logo
Decentralizing Knowledge